The advent of retinoic acid (RA) in the treatment of acute promyelocytic leukemia (APL) has led to a high frequency of short-lasting complete remissions (CR). We studied the response to RA by molecularly analyzing the RA receptor α (RARα) locus, which has recently been shown to be rearranged in all APLs. Southern blot analysis demonstrated that the RARα rearrangements persisted in the APL samples containing maturing myeloid cells 2 to 3 weeks after the start of RA treatment, but disappeared after 5 to 8 weeks, when the patients achieved CR. Our investigations provide clear evidence that CR occurs at molecular level and that there is reconstitution of an apparently normal, nonclonal hematopoiesis. Further, it shows that RA acts by triggering differentiation rather than by exerting a cytotoxic effect on the leukemic clone.

Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia / F. Lo Coco, G. Avvisati, D. Diverio, M. Petti, M. Alcalay, P. Pandolfi, D. Zangrilli, A. Biondi, A. Rambaldi, M. Moleti, P. Pelicci. - In: BLOOD. - ISSN 0006-4971. - 77:8(1991), pp. 1657-1659. [10.1182/blood.v77.8.1657.1657]

Molecular evaluation of response to all-trans-retinoic acid therapy in patients with acute promyelocytic leukemia

M. Alcalay;A. Rambaldi;P. Pelicci
1991

Abstract

The advent of retinoic acid (RA) in the treatment of acute promyelocytic leukemia (APL) has led to a high frequency of short-lasting complete remissions (CR). We studied the response to RA by molecularly analyzing the RA receptor α (RARα) locus, which has recently been shown to be rearranged in all APLs. Southern blot analysis demonstrated that the RARα rearrangements persisted in the APL samples containing maturing myeloid cells 2 to 3 weeks after the start of RA treatment, but disappeared after 5 to 8 weeks, when the patients achieved CR. Our investigations provide clear evidence that CR occurs at molecular level and that there is reconstitution of an apparently normal, nonclonal hematopoiesis. Further, it shows that RA acts by triggering differentiation rather than by exerting a cytotoxic effect on the leukemic clone.
Settore MED/15 - Malattie del Sangue
Settore MED/03 - Genetica Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
1657.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.2 MB
Formato Adobe PDF
1.2 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/810430
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 72
  • ???jsp.display-item.citation.isi??? 74
social impact